Use of Heart Medications in Finnish Coronary Patients
Author Information
Author(s): Kristiina Manderbacka, Ilmo Keskimäki, Antti Reunanen, Timo Klaukka
Primary Institution: National Research and Development Centre for Welfare and Health
Hypothesis
This study aimed to describe the use of antithrombotic drugs, beta-blockers, and statins among middle-aged Finnish coronary patients and to identify patient groups at risk of inadequate medication for secondary prevention of coronary heart disease.
Conclusion
The use of antithrombotic drugs and beta-blockers among Finnish coronary patients was generally appropriate, but statin use was notably low among men with low socioeconomic status.
Supporting Evidence
- 82% of men and 81% of women used beta-blockers.
- 95% of men and 89% of women used antithrombotic drugs.
- 62% of men and 59% of women used statins.
- Younger men and those from higher socioeconomic groups were more likely to use statins.
Takeaway
About half of the Finnish patients with heart disease are taking the right medications to prevent more heart problems, but some groups, like poorer men, are not getting enough of one important medicine.
Methodology
The study used one-year follow-up survey data from a random sample of coronary patients, with a response rate of 54%, and analyzed drug use using logistic regression.
Potential Biases
Potential biases include selective mortality and recall bias in reporting drug use.
Limitations
The study may have biases due to selective non-response and the inability to control for non-CHD related comorbidities.
Participant Demographics
The study included middle-aged Finnish coronary patients, with stratification by gender and socioeconomic status.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website